Departmental Publications

2016 Publications


  1. Correa Cerro LS, Rodriguez FJ, Rodriguez EF. Intravascular malignant cell dissemination pattern in KRAS mutant advanced lung adenocarcinoma: autopsy findings. Int J Clin Exp Pathol 2016 Aug;9(8):8456-63.


  1. Anene DF, Rosenberg AZ, Kleiner DE, Cornish TC, Halushka MK. Utilization of HPASubC for the identification of sinusoid-specific proteins in the liver. J Proteome Res 2016 May 6;15(5):1623-9.
  2. Halushka MK, Angelini A, Bartoloni G, Basso C, Batoroeva L, van der Wal AC. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol 2016 Mar 12;25(3):247-57.
  3. Halushka MK, Mitchell RN, Padera RF. Heart failure therapies: new strategies for old treatments and new treatments for old strategies. Cardiovasc Pathol 2016 Nov - Dec;25(6):503-11.
  4. Halushka MK, van der Wal AC. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol. 2016 May-Jun;25(3):247-57.
  5. McCall MN, Baras AS, Crits-Christoph A, Ingersoll R, McAlexander MA, Witwer KW, Halushka MK. A benchmark for microRNA quantification algorithms using the OpenArray platform. BMC Bioninformatics 2016 Mar;17:138.
  6. Shao Q, Fallica J, Casin KM, Murphy E, Steenbergen C, Kohr MJ. Characterization of the sex-dependent myocardial S-nitrosothiol proteome. Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H505-15.
  7. Witwer KW, Halushka MK. Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research. RNA Biol 2016 Nov;13(11):1103-16.


  1. Eshghi ST, Yang W, Hu Y, Shah P, Sun S, Li X, Zhang H. Classification of Tandem Mass Spectra for Identification of N- and O-linked Glycopeptides. Sci Rep 2016 Nov;6:37189.
  2. Jia X, Chen J, Sun S, Yang W, Yang S, Shah P, Hoti N, Veltri B, Zhang H. Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry. Proteomics. 2016 Dec;16(23):2989-96.
  3. Sokoll LJ, Zhang Z, Chan DW, Reese AC, Bivalacqua TJ, Partin AW, Walsh PC. Do ultrasensitive prostate specific antigen measurements have a role in predicting long-term biochemical recurrence-free survival in men after radical prostatectomy? J Urol 2016 Feb;195(2):330-6.
  4. Sun S, Shah P, Eshghi ST, Yang W, Trikannad N, Yang S, Chen L, Aiyetan P, Höti N, Zhang Z, Chan DW, Zhang H. Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides. Nat Biotechnol. 2016 Jan;34(1):84-8.
  5. Thomas SN, Zhang H. Targeted proteomic assays for the verification of global proteomics insights. Expert Rev Proteomics. 2016 Sep;13(10);897-9.
  6. Yang W, Jackson B, Zhang H. Identification of glycoproteins associated with HIV latently infected cells using quantitative glycoproteomics. Proteomics 2016 Jul;16(13):1872-80.
  7. Yang S, Rubin A, Eshghi ST, Zhang H. Chemoenzymatic method for glycomics: Isolation, identification, and quantitation. Proteomics. 2016 Jan;16(2):241-56.
  8. Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyö D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IeM, Cope L, Pandey A, Zhang B, Snyder MP, Levine DA, Smith RD, Chan DW, Rodland KD; CPTAC Investigators. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016 Jul 28;166(3):755-65.


  1. Ahmed A, VandenBussche CJ, Ali SZ, Olson MT. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration. Diagn Cytopathol 2016 Jan;44(1):10-3.
  2. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology II. Acta Cytol 2016 Sept-Oct;60(5):397-8.
  3. Allison DB, Lilo MT, Geddes S, Pallavajjalla A, Askin F, Gabrielson E, Zheng G, Li QK. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Cancer Cytopathol. 2016 Jul;124(7):485-92.
  4. Allison DB, Maleki Z. HPV-related Head and Neck Squamous Cell Carcinoma: An Update and Review Article. J Am Soc Cytopathol. 2016 July-Aug;5(4):203-15.
  5. Allison DB, Miller JA, Coquia SF, Maleki Z. Ultrasonography-guided fine-needle aspiration with concurrent small core biopsy of neck masses and lymph nodes yields adequate material for HPV testing in head and neck squamous cell carcinomas. J Am Soc Cytopathol 2016 Jan/Feb;5(1):22-30.
  6. Allison DB, Olson MT, Lilo M, Zhang ML, Rosenthal DL, VandenBussche CJ. Should BK polyoma virus cytopathic effect be best classified as atypical or benign in urine cytology specimens? Cancer Cytopathol. 2016 Jun;124(6):436-42.
  7. Allison DB, Olson MT, Maleki Z, Ali SZ. Metastatic urinary tract cancers in pap test: Cytomorphologic findings and differential diagnosis. Diagn Cytopathol 2016 Dec;44(12):1078-81.
  8. Bishop JA, French CA, Ali SZ. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients. Cancer. 2016 Dec;124(12):901-8.
  9. Cowan ML, Li QK, Illei PB. CDX-2 expression in primary lung adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):16-9.
  10. Collins JA, Ali SZ, VandenBussche CJ. Pancreatic cytopathology. Surg Path Clins 2016 Dec;9(4):661-76.
  11. Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ. Mesothelin expression in advanced gastroesophageal cancer represents a novel target for immunotherapy. Appl Immunohistochem Mol Morphol 2016 Apr;24(4):246-52.
  12. Lee J, Rodriguez F, Ali SZ. Metastatic Gliosarcoma: Cytopathologic Characteristics with Histopathologic Correlations. Acta Cytol 2016 Sept - Oct;60(5):490-4.
  13. Lilo MT, Allison D, Wang Y, Ao MH, Gabrielson E, Geddes S, Zhang H, Askin F, Li QK. Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. J Am Soc Cytopathol 2016 May-June;5(3):123-32.
  14. Rerkpichaisuth V, Collins JA, Boonyaarunnate T, Ali SZ Well-differentiated fetal adenocarcinoma of the lung mimicking adenoid cystic carcinoma on fine needle aspiration: A case report. Diagn Cytopathol. 2016 Nov;44(11):917-20.
  15. Rodriguez EF, Monaco SE. Recent advances in the pathology and molecular genetics of lung cancer: A practical review for cytopathologists. J Am Soc Cytopathol 2016 Sept-Oct;5(5):252-65.
  16. Rooper LM, Ali SZ, Olson MT. A Minimum Volume of 60 mL is Necessary to Ensure That a Pericardial Effusion is Benign: A Retrospective Review of 480 Pericardiocentesis Specimens from 1994-2013. Am J Clin Pathol 2016 Jan; 145(1):101-6.
  17. Rooper LM, Ali SZ, Olson MT. A specimen volume of ≥l80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases. J Am Soc Cytopathol 2016 Sept-Oct;5(5):301-5.
  18. Rooper LM, Nikolskaia O, Carter J, Ning Y, Lin MT, Maleki Z. A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases. Hum Pathol. 2016 May;51:139-45.
  19. Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Hum Pathol. 2016 Aug;54:8-16.
  20. VandenBussche CJ. The Paris System for Reporting Urinary Cytology. Cytopathology 2016 Jun;27(3):153-6.
  21. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y. Am J Surg Pathol 2016 Aug;40(8):1090-9.
  22. VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol 2016 Mar;124(3):174-80.
  23. VandenBussche CJ, Sathiyamoorthy S, Wakely PE Jr, Ali SZ. Chondroblastic osteosarcoma: Cytomorphologic characteristics and differential diagnosis on FNA. Cancer Cytopathol. 2016 Jul;124(7):493-500.
  24. Wong YP, Sharifah NA, Tan GC, Gill AJ, Ali SZ. Intrathyroidal oxyphilic parathyroid carcinoma: A potential diagnostic caveat in cytology? Diagn Cytopathol 2016 Aug;44(8):688-92.
  25. Zhang ML, Rosenthal DL, VandenBussche CJ. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type. Cancer Cytopathol. 2016 Aug;124(8):552-64.
  26. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol. 2015 Jul;39(7):939-47.
  27. Waters KM, Ali SZ, Erozan YS, Olson MT. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor. Diagn Cytopathol 2015 Jan;43(1):45-8.


  1. Adsay V, Jang JY, Klimstra DS, Hruban RH; Members of the Verona Consensus Meeting, 2013. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona Consensus Meeting. Ann Surg. 2016 Jan;263(1):162-77.
  2. Bai H, Zhu Q, Surcel A, Luo T, Ren Y, Guan B, Liu Y, Wu N, Joseph NE, Wang TL, Zhang N, Pan D, Alpini G, Robinson DN, Anders RA. Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization. Am J Physiol Gastrointest Liver Physiol 2016 Sep 1;311(3):G396-411.
  3. Bhaijee F, Anders RA. PD-L1 Expression as a Predictive Biomarker: Is Absence of Proof the Same as Proof of Absence? JAMA Oncol. 2016 Jan;2(1):54-5.
  4. Brosens LA, Wood LD, Offerhaus GJ, Arnold CA, Lam-Himlin D, Giardiello FM, Montgomery EA. Pathology and Genetics of Syndromic Gastric Polyps. Int J Surg Pathol 2016 May;24(3):185-99.
  5. Dal Molin M, Brant A, Blackford AL, Griffin JF, Shindo K, Barkley T, Rezaee N, Hruban RH, Wolfgang CL, Goggins M. Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma. PLoS One. 2016 Oct 12;11(10):e0164195.
  6. Dal Molin MD, Kim H, Blackford A, Sharma R, Goggins M. Glucagon-like peptide-1 receptor expression in normal and neoplastic human pancreatic tissues. Pancreas 2016 Apr;45(4):613-9.
  7. Dudley JC, Lin MT, Le DT, Eshleman JR. Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res 2016 Feb;22:813-20.
  8. Elgogary A, Xu Q, Poore B, Alt J, Zimmermann SC, Zhao L, Fu J, Chen B, Xia S, Liu Y, Neisser M, Nguyen C, Lee R, Park JK, Reyes J, Hartung T, Rojas CJ, Rais R, Tsukamoto T, Semenza GL, Hanes J, Slusher BS, Le A. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci USA 2016 Sep 6;113(36):E5328-36.
  9. Gupta RK, Xie BH, Patton KT, Lisovsky M, Biurks E, Behrman SW, Klimstra D, Deshpande V. Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms. Hum Pathol. 2016 Feb;48:154-62.
  10. Hackeng WM, Brosens LA, Poruk KE, Noë M, Hosoda W, Poling JS, Rizzo A, Campbell-Thompson M, Atkinson MA, Konukiewitz B, Klöppel G, Heaphy CM, Meeker AK, Wood LD. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis. Hum Pathol. 2016 Oct;56:93-100.
  11. Hata T, Dal Molin M, Suenaga M, Yu J, Pittman M, Weiss MJ, Canto M, Wolfgang CL, Lennon AM, Hruban AM, Goggins MG. Cyst fluid telomerase activity predicts the histologic grade of cystic neoplasms of the pancreas. Clin Cancer Res. 2016 Oct 15;22(20):5141-51.
  12. Hosoda W, Wood LD. Molecular genetics of pancreatic neoplasms. Surg Path Clin 2016 Dec;9(4):685-703.
  13. Jhaveri DT, Kim MS, Thompson ED, Huang L, Sharma R, Klein AP, Zheng L, Le DT, Laheru DA, Pandey A, Jaffee EM, Anders RA. Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer. Cancer Immunol Res. 2016 Mar;4(3):225-33.
  14. Omura N, Mizuma M, MacGregor A, Hong SM, Ayars M, Almario JA, Borges M, Kanda M, Li A, Vincent A, Maitra A, Goggins M. Overexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget. 2016 Jun 7;7(23):34977-87.
  15. Pittman ME, Brosens LAA, Wood LD. Genetic Syndromes with Pancreatic Manifestations. Surg Path Clins 2016 Dec;9(4):705-15.
  16. Pittman ME, Khararjian A, Wood LD, Montgomery EA, Voltaggio L. Prospective identification of Helicobacter pylori in routine gastric biopsies without reflex ancillary stains is cost-efficient for our health care system. Hum Pathol 2016 Dec;58:90-6.
  17. Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD*, Wolfgang CL*. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford) 2016 Mar; 18(3):236-46.
  18. Roberts NJ, Norris AL, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov 2016 Feb;6(2):166-75.
  19. Sato N, Kohi S, Hirata K, Goggins M. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight. Cancer Sci 2016 May;107(5):569-75.
  20. Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system. CA Cancer J Clin. 2016 Sep;66(5):408-36.


  1. Ahearn TU, Pettersson A, Ebot EM, Gerke T, Greaff RE, Morais CL, Hicks JL, Wilson KM, Rider FR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer. JNCI 2016 Feb;108(2): djv346 (9 pages).
  2. Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MAM, Wang Y, Kinde I, Vandenbussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Mod Pathol. 2016 May;29(5):511-5.
  3. Diolombi ML, Khani F, Epstein JI. Diagnostic dilemmas in enlarged and diffusely hemorrhagic adrenal glands. Hum Pathol 2016 Jul;53:63-72.
  4. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016 Feb;40(2):244-52.
  5. Epstein JI, Montironi R. Grading of prostate cancer in the 21st century. Urologia 2016 Mar 5;82(1):1-3.
  6. Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A contemporary prostate cancer grading system: a validated alternative to the Gleason Score. Eur Urol 2016 Mar;69(3):428-35.
  7. Faraj SF, Bezerra SM, Yousefi K, Fedor H, Glavaris S, Han M, Partin AW, Humphreys E, Tosoian J, Johnson MH, Davicioni E, Trock BJ, Schaeffer EM, Ross AE, Netto GJ. Clinical validation of the 2005 ISUP Gleason Grading System in a cohort of intermediate and high risk men undergoing radical prostatectomy. PLoS One 2016 Jan;11(1):e0146189.
  8. Guedes LB, Morais CL, Almutairi F, Haffner MC1, Zheng Q, Isaacs JT, Antonarakis ES, Lu C, Tsai H, Luo J, De Marzo AM, Lotan TL. Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. Clin Cancer Res. 2016 Sep 15;22(18):4651-63.
  9. Haffner MC, Barbieri CE. Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia. Eur Urol. 2016 May;69(5):831-3.
  10. Haffner MC, Weier C, Xu MM, Vaghasia A, Gürel B, Gümüşkaya B, Esopi DM, Fedor H, Tan HL, Kulac I, Hicks J, Isaacs WB, Lotan TL, Nelson WG, Yegnasubramanian S, De Marzo AM. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J Pathol 2016 Jan;238(1):31-41.
  11. Hedayati M*, Haffner MC*, Coulter J, Raval RR, Zhang Y, Zhou H, Mian O, Knight EJ, Dalrymple S, Isaacs JT7, Santos A, Hales RK, Razavi N, Nelson WG, Yegnasubramanian S, DeWeese TL. Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation. Clin Cancer Res. 2016 Jul 1;22(13):3310-9.
  12. Kates M, Sopko NA, Han M, Partin AW, Epstein JI. Importance of reporting the Gleason score at the positive surgical margin site: an analysis of 4,082 consecutive radical prostatectomy cases. J Urol Feb 2016;195:337-42.
  13. Kawahara T, Aljarah AK, Shareef HK, Inoue S, Ide H, Patterson JD, Kashiwagi E, Han B, Li Y, Zheng Y, Miyamoto H. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine. Prostate 2016 Jun;76(8):744-56.
  14. Kawahara T, Kashiwagi E, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis. Mol Carcinog 2016 Feb;55(2):161-9.
  15. Kryvenko ON, Balise R, Prakash NS, Epstein JI. African-American men with Gleason score 3+3=6 prostate cancer produce less prostate specific antigen than caucasian men: a potential impact on active surveillance. Urol 2016 Feb;195(2):301-6.
  16. Kryvenko ON, Diaz M, Matoso A, Kates M, Cohen J, Swanson GP, Epstein JI. Prostate-specific antigen mass density-A measure predicting prostate cancer volume and accounting for overweight and obesity-related prostate-specific antigen hemodilution. Urology 2016 Apr;90:141-7.
  17. Kryvenko ON, Epstein JI. Changes in prostate cancer grading: including a new patient-centric grading system. Prostate 2016 Apr;76(5):427-33.
  18. Kryvenko ON, Epstein JI. Definition of insignificant tumor volume of Gleason score 3+3=6 (Grade Group 1) prostate cancer at radical prostatectomy - Is it time to increase the threshold? J Urol 2016 Dec;196(6):1664-9.
  19. Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L7, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M6, Lin DW10, Nelson PS, Thompson IM, True LD, Brooks JD, Lance R, Troyer D, Squire JA. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Mod Pathol. 2016 Aug;29(8):904-14.
  20. Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PTEN loss as determined by clinical-grade immunohistochemistry assay is associated with worse recurrence-free survival in prostate cancer. European Urology Focus 2016 June;2(2):180-8.
  21. Magi-Galluzzi C, Montironi R, Epstein JI. Contemporary Gleason grading and novel Grade Groups in clinical practice. Curr Opin Urol. 2016 Sep;26(5):488-92.
  22. Matoso A, Chen YB, Rao V, Wang L, Cheng L, Epstein JI. Atypical renal cysts: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol 2016 Feb;40(2):202-11.
  23. Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016 Mar;17(3):25.
  24. Matoso A, Fabre V, Quddus MR, Lepe M, Lombardo KA, Manna P, Epstein JI. Prevalence and distribution of 15 high-risk human papillomavirus types in squamous cell carcinoma of the scrotum. Hum Pathol. 2016 Jul;53:130-6.
  25. Morais CL, Guedes LB, Hicks J, Baras AS, De Marzo AM, Lotan TL. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma. Hum Pathol. 2016 Sep;55:117-25.
  26. Munari E, Chaux A, Vaghasia AM, Taheri D, Karram S, Bezerra SM, Gonzalez Roibon N, Nelson WG, Yegnasubramanian S, Netto GJ, Haffner MC. Global 5-hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies. PLoS One 2016 Jan 19;11(1):e0146302.
  27. Netto GJ. Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma. Lancet. 2016 May 7;387(10031):1881-2.
  28. Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Ricardo BF, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Virchows Arch. 2016 Oct;469(4):427-3.
  29. Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ, Schoenberg MP, Epstein JI1, Netto GJ. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Hum Pathol 2016 Jan;47(1):20-5.
  30. Sadimin ET, Epstein JI. Round cell pattern of prostatic stromal tumor of uncertain malignant potential: a subtle newly recognized variant. Hum Pathol 2016 Jun;52:68-73.
  31. Sadimin ET, Khani F, Diolombi M, Meliti A, Epstein JI. Interobserver reproducibility of percent Gleason pattern 4 in prostatic adenocarcinoma on prostate biopsiesc. Am J Surg Pathol 2016 Dec;40(12):1686-92.
  32. Sadimin ET, Ye H, Epstein JI. Should the involvement of skeletal muscle by prostatic adenocarcinoma be reported on biopsies? Hum Pathol 2016 Mar;49:10-4.
  33. Schwartz LE, Khani F, Bishop JA, Vang R, Epstein JI. Carcinoma of the uterine cervix involving the genitourinary tract: a potential diagnostic dilemma. Am J Surg Pathol 2016 Jan;40(1):27-35.
  34. Shekhani MT, Barber JR, Bezerra SM, Heaphy CM, Gonzalez Roibon ND, Taheri D, Reis LO, Guner G, Joshu CE, Netto GJ, Meeker AK High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors. Hum Pathol. 2016 Aug;54:106-12.
  35. Trock BJ, Fedor H, Gurel B, Jenkins RB, Knudsen BS, Fine SW, Said JW, Ballentine Carter H. Lotan TL, De Marzo AM. PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance. Mod Pathol 2016 Jul;29(7):764-71.
  36. Weber KA, Heaphy CM, Rohrmann S, Gonzalez B, Bienstock J, Agurs-Collins T, Platz EA, Meeker AK. Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer? Prostate Cancer 2016;2016:3691650.
  37. Wobker SE, Aron M, Epstein JI. Mechanical implantation of urothelium into periureteral soft tissue: A series of 4 cases mimicking high stage urothelial carcinoma. Am J Surg Pathol 2016 Nov;40:1564-70.
  38. Wobker SE, Epstein JI. Differential diagnosis of intraductal lesions of the prostate. Am J Surg Pathol. 2016 Jun;40(6):e67-82.
  39. Wobker SE, Przybycin CG, Sircar K, Epstein JI. Renal oncocytoma with vascular invasion: a series of 22 cases. Hum Pathol 2016 Dec;58:1-6.


  1. Bynum J, Murphy KM, DeScipio C, Beierl K, Adams E, Anderson D, Vang R, Ronnett BM. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping. Int J Gynecol Pathol Int J Gynecol Pathol. 2016 Mar;35(2):134-41.
  2. Jiang RT, Schellenbacher C, Chackerian B, Roden RB. Progress and prospects for L2-based human papillomavirus vaccines. Expert Rev Vaccines. 2016 Jul;15(7):853-62.
  3. Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL. Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1. Cancer Res. 2016 Nov 1;76(21):6351-61.
  4. Kuhn E, Wang TL, Doberstein K, Bahadirli-Talbott A, Ayhan A, Sehdev AS, Drapkin R, Kurman RJ, Shih IeM. CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma. Mod Pathol. 2016 Oct;29(10):1254-61.
  5. Kurman RJ, Shih IeM. Seromucinous Tumors of the Ovary. What's in a Name? Int J Gynecol Pathol. 2016 Jan;35(1):78-81.
  6. Kurman RJ, Shih IeM. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol 2016 Apr;186(4):733-47.
  7. Lee SJ, Yang A, Wu TC, Hung CF. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. J Gynecol Oncol. 2016 Sep;27(5):e51.
  8. Peng S, Qiu J, Yang A, Yang B, Jeang J, Wang JW, Chang YN, Brayton C, Roden RB, Hung CF, Wu TC. Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. Cell Biosci 2016 Feb 25;6:16.
  9. Soong RS, Anchoori RK, Yang B, Yang A, Tseng SH, He L, Tsai YC, Roden RB, Hung CF. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells. Oncotarget. 2016 Oct 18;7(42):68489-502.
  10. Sun YY, Peng S, Han L, Qiu J, Song L, Tsai Y, Yang B, Roden RB, Trimble CL, Hung CF, Wu TC. Local HPV recombinant vaccinia boost following priming with an HPV DNA vaccine enhances local HPV-specific CD8+ T-cell-mediated tumor control in the genital tract. Clin Cancer Res 2016 Feb 1;22(3):657-69.
  11. Suryo Rahmanto Y, Jung JG, Wu RC, Kobayashi Y, Heaphy CM, MeekerAK, Wang TL*, Shih IeM. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. J Biol Chem. 2016 Apr 29;291(18):9690-9. * co-senior author.
  12. Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IeM, Kurman RJ. Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in The Cancer Genome Atlas ovarian study. Int J Gynecol Pathol 2016 Jan;35(1):48-55.
  13. Xing D, Schoolmeester JK, Ren Z, Isacson C, Ronnett BM. Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection. Am J Surg Pathol 2016 Apr;40(4):529-36.
  14. Yang A, Farmer E, Wu TC, Hung CF. Perspectives for therapeutic HPV vaccine development. J Biomed Sci 2016 Nov;23:75.


  1. Achanta P, Steranka JP, Tang Z, Sharma R, Yang WR, Ma S, Grivainis M, Huang CRL, Schneider AM, Gallia GL, Riggins GJ, Quinones-Hinojosa A, Fenyo D, Boeke JD, Burns KH. Somatic retrotransposition is infrequent in glioblastomas. Mobile DNA 2016 Nov;7:22.
  2. Crane GM, Duffield AS. Hematolymphoid lesions of the sinonasal tract. Semin Diagn Pathol 2016 Mar;33(2):71-80.
  3. Crane GM, Samols MA, Morsberger LA, Yonescu R, Thiess ML, Batista DA, Ning Y, Burns KH, Vuica-Ross M, Borowitz MJ, Gocke CD, Ambinder RF, Duffield AS. Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived. PLoS One. 2016 Sep 29;11(9):e0163559.
  4. Keeney M, Wood BH, Hedley B, DiGiuseppe JA, Stetler-Stevenson M, Paietta E, Lozanski G, Seegmiller AC, Greig BW, Shaver AC, Mukundan L, Higley HR, Sigman CC, Kelloff G, Jessup JM, Borowitz MJ. Experience with MRD Testing in B- ALL By Flow Cytometry Does Not Prevent Interpretative Discordance. Blood 2016 Dec;128(22):2907.
  5. Song JY, Venkataraman G, Fedoriw YD, Alikhan M, Kim Y, Weisenburger DD, Collins J, Liu Xueli, Duffield AS. Burkitt Leukemia limited to the bone marrow has a better prognosis than Burkitt Lymphoma with bone marrow involvement in adults. Leuk Lymphoma 2016 Apr;57(4):866-71.
  6. Zampella JG, Rodić N, Yang WR, Huang CR, Welch J, Gnanakkan VP, Cornish TC, Boeke JD, Burns KH. A map of mobile DNA insertions in the NCI-60 human cancer cell panel. Mob DNA. 2016 Oct 31;7:20.


  1. Barin JG, Talor MV, Schaub JA, Diny NL, Hou X, Hoyer M, Archer NK, Gebremariam ES, Davis MF, Miller LS, Rose NR, Čiháková D. Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol 2016 Sep;186(9):2337-52.
  2. Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P. Reactive oxygen species in organ-specific autoimmunity. Auto Immun Highlights 2016 Dec;7(1):11.
  3. Diny NL, Hou X, Barin JG, Chen G, Talor MV, Schaub J, Russell SD, Klingel K, Rose NR, Čiháková D. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur J Immunol. 2016 Dec;46(12):2749-2760.
  4. Hamad AR, Ahmed R, Donner T, Fousteri G. B cell-targeted immunotherapy for type 1 diabetes: What can make it work? Discov Med. 2016 Mar;21(115):213-9.
  5. Martina MN, Noel S, Saxena A, Bandapalle S, Majithia R, Jie C, Arend LJ, Allaf ME, Rabb H, Rahim A Hamad A. Double-negative αβ T cells are early responders to AKI and are found in human kidney. J Am Soc Nephrol 2016 Apr;27(4):1113-23.
  6. Ong S, Rose NR, Cihakova D. Natural killer cells in inflammatory heart disease. Clin Immunol. 2016 Nov;175:26-33.
  7. Ramirez L, Hamad AR. From non-obese diabetic to Network for the Pancreatic Organ Donor with Diabetes: New heights in type 1 diabetes research. World J Diabetes 2015 Nov 25;6(16):1309-11.
  8. Ricciuti A, Travison TG, Di Dalmazi G, Talor MV, DeVincentiis L, Manley RW, Bhasin S, Caturegli P*, Basaria S*. A Subset of men with age-related decline in testosterone have gonadotroph autoantibodies. J Clin Endocrinol Metab 2016 Apr;101(4):1535-41. (*= co-senior author)
  9. Sadegh-Nasseri. A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells. F1000 Res - 2016;5:F1000 Faculty Rev-1305.
  10. Sadegh-Nasseri S, Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Mol Immunol 2015 Dec;68(2 Pt A):81-4.
  11. Schroeder LF, Guarner J, Elbireer A, Castle PE, Amukele T. Time for a model list of essential diagnostics. N Engl J Med. 2016 Jun 30;374(26):2511-4.
  12. Schroeder, LF, LaBarre P, Weigl BH, Amukele T. The next phase for point-of-care testing in resource-limited settings: noncommunicable disease. Point of Care 2016 June;15(2):93-5.
  13. Schroeder LF, Elbireer A, Jackson JB, Amukele TK. Laboratory diagnostics market in East Africa: a survey of test types, test availability, and test prices in Kampala, Uganda. PLoS One 2015 Jul 30;10(7):e0134578.
  14. Schütz C, Varela JC, Perica K, Haupt C, Oelke M, Schneck JP. Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells. Oncotarget 2016 Oct 18;7(42):68503-12.
  15. Sharma R, Di Dalmazi G, Caturegli P. Exacerbation of autoimmune thyroiditis by CTLA-4 blockade: a role for IFNγ-induced indoleamine 2, 3-dioxygenase. Thyroid 2016 Aug;26(8):1117-24.
  16. Wu L, Diny NL, Ong S, Barin JG, Hou X, Rose NR, Talor MV, Čiháková D. Pathogenic IL-23 signaling is required to initiate GM-CSF-driven autoimmune myocarditis in mice. Eur J Immunol. 2016 Mar;46(3):582-92.


  1. None reported


  1. Amukele TK, Street J, Carroll K, Miller H, Zhang SX. Drone Transport of Microbes in Blood and Sputum Laboratory Specimens. J Clin Microbiol. 2016 Oct;54(10):2622-5.
  2. Avery RK, Arav-Boger R, Marr KA, Kraus E, Shoham S, Lees L, Trollinger B, Shah P, Ambinder R, Neofytos D, Ostrander D, Forman M, Valsamakis A. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection. Transplantation. 2016 Oct;100(10):e74-80.
  3. Carroll KC. Biographical Feature: Patrick R. Murray, Ph.D. J Clin Microbiol. 2016 Aug;54(8):1942-5.
  4. Cobb BR, Valsamakis A. Chronic hepatitis B, C, and D. Microbiol Spectr. 2016 Aug;4(4):1-16.
  5. Cosgrove SE, Li DX, Tamma PD, Avdic E, Hadhazy E, Wakefield T, Gherna M, Carroll KC. Use of PNA FISH for blood cultures growing Gram-positive cocci in chains without a concomitant antibiotic stewardship intervention does not improve time to appropriate antibiotic therapy. Diagn Microbiol Infect Dis 2016 Sep;86(1):86-92.
  6. Eghrari AO, Gibas C, Watkins T, Vahedi S, Lee R, Houle E, Suarez MJ, Eberhart C, Sutton DA, Wiederhold NP, Sikder S, Zhang SX. First Human Case of Fungal Keratitis Caused by a Putatively Novel Species of Lophotrichus. J Clin Microbiol. 2015 Sep;53(9):3063-7.
  7. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynne PM, Chipato T, McIntyre J, Gnananshanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM for the IMPAACT 1077BF/1077 FF PROMISE Study Team. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Eng J Med Nov 2016;375:1726-37.
  8. Gniadek TJ, Carroll KC, Simner PJ. Carbapenem-Resistant Glucose Non-Fermenting Gram-Negative Bacilli: The Missing Piece to the Puzzle. J Clin Microbiol. 2016 Jul;54(7):1700-10.
  9. Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood 2016 Apr 21;127(16):2007-17.
  10. Kuo IC, Espinosa C, Forman M, Valsamakis A. A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees. Am J Ophthalmol 2016 Mar;163:38-44.
  11. Lyons JL, Zhang SX. Current laboratory approaches to diagnosis of CNS fungal infections. Future Microbiology 2016 February; 11:175-7.
  12. Riedel S, Carroll KC. Early Identification and Treatment of Pathogens in Sepsis: Molecular Diagnostics and Antibiotic Choice. Clin Chest Med. 2016 Jun;37(2):191-207.
  13. Simner PJ, Doerr KA, Steinmetz LK, Wengenack NL. Mycobacterium and aerobic actinomycete culture: are two medium types and extended incubation times necessary? J Clin Microbiol 2016 Apr;54(4):1089-93.
  14. Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrob Risist Infect Control May 2016;5:15.
  15. Suwantarat N, Romagnoli M, Carroll KC. Photo quiz: isolation of an unusual gram-positive coccus from a positive blood culture in a patient with pneumonia. Clin Microbiol 2016 Jan;54(1):1.
  16. Suwantarat N, Romagnoli M, Carroll KC. Answer to January 2016 Photo Quiz. J Clin Microbiol 2016 Jan;54(1):247.
  17. Suwantarat N, Weik C, Romagnoli M, Ellis BC, Kwiatkowski N, Carroll KC. Practical utility and accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of corynebacterium species and other medically relevant coryneform-like bacteria. Am J Clin Pathol 2016 Jan;145(1):22-8.
  18. Tamma PD, Huang Y, Opene BN, Simner PJ. Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6425-9.
  19. Valsamakis A. Editorial Commentary: Standardization of Viral Load Testing for Cytomegalovirus: The Long Road Just Got Longer. Clin Infect Dis. 2016 Sep 1;63(5):590-3.
  20. Workneh M, Wang F, Romagnoli M, Simner PJ, Carroll K. Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe. Anaerobe. 2016 Dec;42:98-100.
  21. Zhang SX, Wiederhold NP. Yeasts. Microbiol Spectr. 2016 Aug;4(4):1-20.


  1. Belchis DA, Tseng LH, Gniadek T, Haley L, Lokhandwala P, Illei P, Gocke CD, Forde P, Brahmer J, Askin FB, Eshleman JR, Lin MT. Heterogeneity of resistance mutations detectable by nextgeneration sequencing in TKI-treated lung adenocarcinoma. Oncotarget 2016 Jul 19;7(29):45237-48.
  2. Gondek LP, Zheng G, Ghiaur G, DeZern AE1, Matsui W, Yegnasubramanian S, Lin MT, Levis M, Eshleman JR, Varadhan R, Tucker N, Jones R, Gocke CD. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia. 2016 Sep;30(9):1916-20.
  3. Ho H, Skaist AM, Pallavajjalla A, Yonescu R, Batista D, Wheelan SJ, Ning Y. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells. Leuk Res. 2016 Jun;45:1-7.
  4. Morsberger L, Powell K, Ning Y. A marker chromosome in post-transplant bone marrow. Molec Cytogenetics 2016 June;9:42.
  5. Ning Y. A cryptic translocation leading to NUP98-PHF23 fusion in AML. Best Pract Res Clin Haematol 2016 Dec;29(4):320-3.
  6. Zheng G, Lin MT, Lokhandwala PM, Beierl K, Netto GJ, Gocke CD, Eshleman JR, McCarthy E, Illei PB. Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencing. Cancer. 2016 Oct;124(10):744-53.
  7. Zheng G, Tsai H, Tseng LH, Illei P, Gocke CD, Eshleman JR, Netto G, Lin MT. Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimens. Am J Clin Pathol 2016 May;145(5):696-702.


  1. Asch-Kendrick RJ, Burton E, Chen L, Nauen D. A 74-year-old man with a jugular foramen mass. Brain Pathol 2016 Jan;26(1):124-5.
  2. Chang Q, Martin LJ. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS. Neurobiol Dis 2016 Sep;93:78-95.
  3. Eberhart C. Multiple cilia suppress tumour formation. Nat Cell Biol. 2016 Mar 30;18(4):368-9.
  4. Fayzullina S, Martin LJ. DNA Damage response and DNA repair in skeletal Myocytes from a mouse model of spinal muscular atrophy. J Neuropathol Exp Neurol 2016 Sep;75(9):889-902.
  5. Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dancik V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees M, Shamji AF, Schreiber SL, Fraenkel E, Pomeroy SL, Mesirov JP, Tamayo P, Eberhart CG, Raabe EH. DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clin Cancer Res. 2016 Aug 1;22(15):3903-14.
  6. Kaur H, Ali SZ, Huey L, Hütt-Cabezas M, Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG*, Raabe EH. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Lett. 2016 Jul 10;377(1):55-64. (corresponding author)
  7. Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, Maciaczyk J, Glunde K, Eberhart C. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int J Cancer 2016 Mar ;138(5):1246-55.
  8. LaClair KD, Donde A, Ling JP, Jeong YH, Chhabra R, Martin LJ, Wong PC. Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model. Acta Neuropathol 2016 Dec;132(6):859-73.
  9. Li T, Braunstein KE, Zhang J, Lau A, Sibener L, Deeble C, Wong PC. Tau repeat domain facilitates pathological conversion of tau through the neuritic plaque in Alzheimer's mice. Nature Communications 2016 July;7: article no. 12082 (open access journal)
  10. Ling JP, Chhabra R, Merran JD, Schaughency PM, Wheelan SJ, Corden JL, Wong PC. PTBP1 and PTBP2 repress nonconserved cryptic exons. Cell Rep 2016 Sep 27;17(1):104-13.
  11. Melnikova T, Park D, Becker L, Lee D, Cho E, Sayyida N, Tian J, Bandeen-Roche K, Borchelt DR, Savonenko AV. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease. Neurobiol Dis 2016 Dec;96:171-85.
  12. Natsumeda M, Maitani K, Liu Y, Miyahara H, Kaur H, Chu Q, Zhang H, D Kahlert U, Eberhart CG. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres. Brain Pathol. 2016 Nov;26(6):713-23.
  13. Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ. Molecular analysis of pediatric oligodendrogliomas highlights genetic differences with adult counterparts and other pediatric gliomas. Brain Pathol 2016 Mar;26(2):206-14.
  14. Pinto AL*, Chen L*, Friedman R, Grant PE, Poduri A, Takeoka M, Prabhu SP, Sahin M. Sturge-Weber syndrome: brain magnetic resonance imaging and neuropathology findings. Pediatr Neurol 2016 May;58:25-30. *Co-first author
  15. Rodriguez FJ. N for nucleus in neurofibromin: new role for an old tumor suppressor? J Neurochem 2016 Jan;136(1):11-2.
  16. Rodriguez O, Schaefer ML, Wester B, Lee YC, Boggs N, Conner HA, Merkle AC, Fricke ST, Albanese C, Koliatsos VE. Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury. J Neurotrauma. 2016 Apr 1;33(7):662-71.
  17. Rodriguez FJ, Vizcaino MA, Blakeley J, Heaphy CM. Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas. Acta Neuropathol 2016 Nov;132(5):761-3.
  18. Rodriguez FJ, Vizcaino MA, Lin MT. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults. J Mol Diagn 2016 Sep;18(5):620-34.
  19. Tabbarah AZ, Robert Bell W, Sun M, Gelwan E, Pletnikova O, Hillis AE, Troncoso JC, Lin MT, Chen L. A rapidly progressive dementia case with pathological diagnosis of FTLD-UPS. Acta Neuropathol. 2016 Aug;132(2):309-11.
  20. Vizcaíno MA, Bishop J, Sharma R, Refaey K, Quiñones-Hinojosa A, Rodriguez FJ. Intracranial solitary fibrous tumor/ hemangiopericytoma with osteoclast-like multinucleated giant cells: comparison with giant cell-rich solitary fibrous tumor. Clin Neuropathol. 2016 Jul-Aug;35(4):171-7.


  1. Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, Eberhart CG. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget 2016 Oct;7(43):70028-44.
  2. Asnaghi L, Yang Q, Tripathy A, Hanaford A, Kaur H, Eberhart C. Hypoxia and Notch inhibition both enhance sensitivity of Retinoblastoma cells to Melphalan. Investigative Opthalgy & Vis Sci 2016 Sept;57(12):3662.
  3. Mahale A, Alkatan H, Alwadani S, Othman M, Suarez MJ, Price A, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Deepak EP, Eberhart CG, Asnaghi L. Altered gene expression in conjunctival squamous cell carcinoma. Mod Pathol 2016 May;29(5):452-60.
  4. Suarez MJ, Rivera-Michlig R, Dubovy S, Rodriguez FJ. Clinicopathologic Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum. Ocul Oncol Pathol Apr-June 2016;2:112-21.


  1. Allison DB, Baras AS. Molecular features of urothelial carcinoma of the bladder: A brief overview with histologic and clinical correlates. AJSP 2016 Nov/Dec;21(6):284-92.
  2. Argani P, Reuter VE, Zhang L, Sung YS, Ning Y, Epstein JI, Netto GJ, Antonescu CR. TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity. Am J Surg Pathol. 2016 Nov;40(11):1484-95.
  3. Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Am J Surg Pathol. 2016 Jun;40(6):723-37.
  4. Asch-Kendrick R, Cimino-Mathews A. The role of GATA3 in breast carcinomas: a review. Hum Pathol. 2016 Feb;48:37-47.
  5. Asch-Kendrick RJ, Shetty S, Goldblum JR, Sharma R, Epstein JI, Argani P, Cimino-Mathews A. A Subset of Fat-Predominant Angiomyolipomas Label for MDM2: A Potential Diagnostic Pitfall. Hum Pathol. 2016 Nov;57:7-12.
  6. Bishop JA. Recently described neoplasms of the sinonasal tract. Semin Diagn Pathol. 2016 Mar;33(2):62-70.
  7. Bishop JA, Ha PK. Human papillomavirus detection in a "Digital" age. Cancer 2016 May 15;122(10):1502-4.
  8. Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA. PD-L1 (B7-H1) Expression and the Immune Tumor Microenvironment in Human Primary and Metastatic Breast Carcinomas. Hum Pathol. 2016 Jan;47(1):52-63.
  9. Cimino-Mathews A, Verma S, Figueroa-Magalhaes MC, Jeter SC, Zhang Z, Argani P, Stearns V, Connolly RM. A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma. Am J Clin Pathol. 2016 Mar;145(3):365-72.
  10. Cowan ML, Argani P, Cimino-Mathews A. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins. Mod Pathol 2016 Mar;29(3):259-65.
  11. Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, Del Carmen Rodriguez Pena M, VandenBussche CJ, Olson M, Cunha I, Fujita K, Ertoy D, Kinzler K, Bivalacqua T, Papadopoulos N, Vogelstein B, Netto GJ. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary. Hum Pathol 2016 Jul;53:8-13.
  12. Cowan ML, Thompson LD, Leon ME, Bishop JA. Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature. Head Neck Pathol 2016 Jun;10(2):161-6.
  13. Ma C, Gocke CD, Hruban RH, Belchis DA. Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia. Hum Pathol 2016 Feb;48:117-21.
  14. McCarthy E. The histology of metabolic bone disease. Diagn. Histopathol. 2016 Oct;22(10):378-83.
  15. Rooper LM, Gandhi M, Bishop JA, Westra WH. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Oral Oncol. 2016 Apr;55:11-6.
  16. Rooper LM, Huang SC, Antonescu CR, Westra WH, Bishop JA. Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear â•̚â–“-catenin positivity and absence of SOX10 expression. Hum Pathol. 2016 Sep;55:44-50.
  17. Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol 2016 Apr;40(4):471-8.
  18. Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A*, Emens LA*. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol 2016 Mar;29(3):249-58. * co-senior authors.


  1. Bloch EM, Levin AE, Williamson PC, Cyrus S, Shaz B, Kessler D, Gorlin J, Bruhn R, Lee TH, Montalvo L, Busch MP. A prospective evaluation of chronic B. microti infection in seroreactive blood donors. Transfusion. 2016 Jul;56(7):1875-82.
  2. Bloch EM, Simon MS, Shaz BH. Emerging infections and blood safety in the 21st century. Ann Intern Med. 2016 July;165(1):57-8.
  3. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, Gernsheimer T, Holcomb JB, Kaplan LJ, Katz LM, Peterson N, Ramsey G, Rao SV, Roback JD, Shander A, Tobian AA. Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016 Nov 15;316(19):2025-35.
  4. Chen I, Chau G, Wang J, Clarke W, Marzinke M, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, and Eshleman SH. Analysis of HIV diversity in HIV-infected Black men who have sex with men (HPTN 061). PLoS One 2016 Dec;11(12):e0167629.
  5. Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. HIV Clin Trials. 2016 Jul;17(4):158-64.
  6. Fogel JM, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9.
  7. Glynn SA, Klein HG, Ness PM. The red blood cell storage lesion: the end of the beginning. Transfusion 2016 June;56(6):1462-8.
  8. Goel R, King KE, Takemoto CM, Ness PM, Tobian AA. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012. Transfusion. 2016 Jun;56(6):1451-8.
  9. Grabowski MK, Kong X, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Redd AD, Watya S, Quinn TC, Tobian AAR. Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples. J Infect Dis 2016 Mar;213(6):948-56.
  10. Heddle NM, Ness PM. CONSORT and clinical trial reporting: room for improvement. Transfusion. 2016 Apr;56(4):781-3.
  11. Hulse M, Fader AN, Shan H, Benneh N, Tobian AAR. Massive transfusion in an obstetric emergency. Transfusion 2016 Jan;56:23.
  12. Hume HA, Ddungu H, Angom R, Baluku H, Kajumbula H, Kyeyune-Byabazaire D, Orem J, Ramirez-Arcos S, Tobian AA. Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions. Transfusion 2016 Aug;56(8):1951-9.
  13. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  14. Kaufman MR, Smelyanskaya M, Van Lith LM, Mallalieu B, Waxman A, Hatzhold K, Marcell AV, Kasedde S, Lija J, Hasen N, Ncube G, Samuelson JL, Bonnecwe C, Seifert-Ahanda K, Njeuhmeli E, Tobian AAR. Adolescent sexual and reproductive health services and implications for the provision of voluntary medical male circumcision: results of a systematic review of literature. PLoS One 2016 Mar;11(3):e0149892.
  15. Morar MM, Pitman J, McFarland W, Bloch EM. The Contribution of Unsafe Blood Transfusion to HIV Incidence in sub-Saharan Africa: Re-examination of the 5% to 10% Convention. Transfusion 2016 Dec;56 (12):3121-32.
  16. Plourde A, Bloch EM. A Literature Review of Zika Virus. Emerg Infect Dis. 2016 July;22(7):1185-92.
  17. Tobian AA, Ness PM. Editorial- Red blood cells: aging gracefully in the blood bank. N Engl J Med 2016 Nov;375:1995-7.
  18. Tobian AAR, Reed J, Njeuhmeli E. An evidence-based analysis of voluntary medical male circumcision devices. Nat Rev Urol 2016 May;13(5):295.